Semi-Annual Consolidated Statement Of Cash Flows

CellSeed Inc. - Filing #7272610

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-857,550,000 JPY
-845,584,000 JPY
Depreciation
JPY
7,939,000 JPY
Impairment losses
18,367,000 JPY
112,028,000 JPY
Interest expenses
2,057,000 JPY
1,128,000 JPY
Increase (decrease) in provision for bonuses
163,000 JPY
680,000 JPY
Decrease (increase) in trade receivables
14,745,000 JPY
-26,095,000 JPY
Decrease (increase) in inventories
201,000 JPY
9,974,000 JPY
Increase (decrease) in trade payables
2,404,000 JPY
3,384,000 JPY
Subtotal
-863,276,000 JPY
-777,465,000 JPY
Interest paid
-2,076,000 JPY
-1,032,000 JPY
Income taxes paid
-947,000 JPY
-948,000 JPY
Net cash provided by (used in) operating activities
-866,104,000 JPY
-779,435,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-18,367,000 JPY
-21,632,000 JPY
Net cash provided by (used in) investing activities
-18,367,000 JPY
56,315,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-7,500,000 JPY
-7,500,000 JPY
Net cash provided by (used in) financing activities
855,479,000 JPY
1,814,201,000 JPY
Net increase (decrease) in cash and cash equivalents
-28,992,000 JPY
1,091,081,000 JPY
Cash and cash equivalents
2,134,299,000 JPY
2,163,292,000 JPY
1,072,210,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.